Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Times of Israel) David Shamah - Scientists at the Weizmann Institute may have found the cure for prostate cancer if caught in its early stages - via a drug injected into cancerous cells treated with infrared laser illumination. Using a therapy lasting 90 minutes, the drug, called Tookad Soluble, targets and destroys cancerous prostate cells, studies show. The drug is being marketed by Steba Biotech, an Israeli biotech start-up, and was developed in the lab of Weizmann Institute professors Yoram Salomon and Avigdor Scherz. In a Phase III clinical trial of 80 patients from Latin America, over 80% of the study's subjects remained cancer-free two years after treatment and a similar study in Europe showed similar results.2016-04-08 00:00:00Full Article
Israeli-Developed Drug May Be Prostate Cancer Cure
(Times of Israel) David Shamah - Scientists at the Weizmann Institute may have found the cure for prostate cancer if caught in its early stages - via a drug injected into cancerous cells treated with infrared laser illumination. Using a therapy lasting 90 minutes, the drug, called Tookad Soluble, targets and destroys cancerous prostate cells, studies show. The drug is being marketed by Steba Biotech, an Israeli biotech start-up, and was developed in the lab of Weizmann Institute professors Yoram Salomon and Avigdor Scherz. In a Phase III clinical trial of 80 patients from Latin America, over 80% of the study's subjects remained cancer-free two years after treatment and a similar study in Europe showed similar results.2016-04-08 00:00:00Full Article
Search Daily Alert
|
Search:
|